TQB6411

· Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for TQB6411, covering 2026-01-21 to 2026-03-04. Get the full timeline:

Most recent: Clinical Trial Update: Clinical Trial Evaluating TQB6411 Injection in Subjects With Esophageal Cancer [Phase 1, Phase 2]